Editorial: Covid-19 and Diabetes

Mohamed Abu-Farha; Susanna Hofmann; Hamad Ali

doi:10.3389/fendo.2022.933562

Editorial: Covid-19 and Diabetes

Mohamed Abu-Farha, Susanna Hofmann, Hamad Ali

Kuwait University

Research output: Contribution to journal › Editorial

Original language	English
Article number	933562
Journal	Frontiers in Endocrinology
Volume	13
DOIs	https://doi.org/10.3389/fendo.2022.933562
State	Published - 13 Jun 2022

Keywords

COVID-19
diabetes
diabetes treatment
glycemic control
metformin

Funding Agency

Kuwait Foundation for the Advancement of Sciences

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fendo.2022.933562

Cite this

@article{831cbd60a8a446c091261ff459cb2c0d,

title = "Editorial: Covid-19 and Diabetes",

keywords = "COVID-19, diabetes, diabetes treatment, glycemic control, metformin",

author = "Mohamed Abu-Farha and Susanna Hofmann and Hamad Ali",

year = "2022",

month = jun,

day = "13",

doi = "10.3389/fendo.2022.933562",

language = "English",

volume = "13",

journal = "Frontiers in Endocrinology",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Editorial

T2 - Covid-19 and Diabetes

AU - Abu-Farha, Mohamed

AU - Hofmann, Susanna

AU - Ali, Hamad

PY - 2022/6/13

Y1 - 2022/6/13

KW - COVID-19

KW - diabetes

KW - diabetes treatment

KW - glycemic control

KW - metformin

UR - https://www.scopus.com/pages/publications/85133448026

U2 - 10.3389/fendo.2022.933562

DO - 10.3389/fendo.2022.933562

M3 - Editorial

AN - SCOPUS:85133448026

VL - 13

JO - Frontiers in Endocrinology

JF - Frontiers in Endocrinology

M1 - 933562

ER -

Editorial: Covid-19 and Diabetes

Keywords

Funding Agency

UN SDGs

Access to Document

Other files and links

Cite this